News | August 30, 2024
Ayurvedic Whole System effective in Managing Rheumatoid Arthritis: Study
The study highlighted substantial improvements in key clinical parameters among RA patients who underwent AWS intervention
The study highlighted substantial improvements in key clinical parameters among RA patients who underwent AWS intervention
Under the terms of the agreement, Biogen will make an upfront payment of US $ 8 million to Xbrane
Grant of Permission to manufacture and market FDC of Naproxen Delayed Release and Esomeprazole capsule (375mg/500mg + 20mg/20mg)
The Complement Laboratory is equipped with state-of-the-art immunoturbidimetric and ELISA platforms and adheres to CAP and NABL accreditation standards
Gobivaz is authorised for adults with rheumatoid arthritis (in combination with methotrexate), psoriatic arthritis (with or without methotrexate), axial spondyloarthritis, and ulcerative colitis
Tofacitinib extended-release tablets are a Janus kinase inhibitor indicated for Rheumatoid Arthritis
The SELECT-SWITCH study, first head-to-head Phase 3b/4 trial, compared switching to Rinvoq versus switching to another TNF inhibitor
MKP11093 has shown strong results in preclinical studies with a promising safety and selectivity profile
Celecoxib is a nonsteroidal anti-inflammatory drug
Lupin and Zentiva sign license and supply agreement for commercializing Certolizumab
Subscribe To Our Newsletter & Stay Updated
